Arrowstreet Capital Limited Partnership trimmed its holdings in shares of Ralliant Corporation (NYSE:RAL – Free Report) by 15.4% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 1,463,778 shares of the company’s stock after selling 265,500 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Ralliant were worth $60,879,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in RAL. Bank of Nova Scotia boosted its position in Ralliant by 571.1% during the 1st quarter. Bank of Nova Scotia now owns 162,400 shares of the company’s stock valued at $6,754,000 after buying an additional 138,200 shares during the period. Sei Investments Co. grew its holdings in shares of Ralliant by 193.7% during the 1st quarter. Sei Investments Co. now owns 182,342 shares of the company’s stock worth $7,583,000 after acquiring an additional 120,248 shares during the period. Walleye Capital LLC bought a new position in Ralliant in the first quarter worth $4,525,000. First Trust Advisors LP lifted its position in Ralliant by 7.7% during the 1st quarter. First Trust Advisors LP now owns 95,937 shares of the company’s stock valued at $3,990,000 after acquiring an additional 6,897 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in shares of Ralliant by 60.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,314,834 shares of the company’s stock worth $54,669,000 after buying an additional 496,171 shares during the last quarter.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on the stock. Oppenheimer raised their price objective on shares of Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Evercore started coverage on Ralliant in a research report on Tuesday, June 9th. They issued an “outperform” rating and a $80.00 target price on the stock. Royal Bank Of Canada lifted their price objective on Ralliant from $64.00 to $71.00 and gave the company a “sector perform” rating in a research report on Thursday, July 16th. Wall Street Zen downgraded shares of Ralliant from a “buy” rating to a “hold” rating in a report on Sunday. Finally, Citigroup increased their price objective on shares of Ralliant from $70.00 to $81.00 and gave the company a “buy” rating in a report on Monday, July 13th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $73.00.
Ralliant Trading Up 0.5%
NYSE:RAL opened at $69.75 on Tuesday. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 0.73. The firm has a fifty day simple moving average of $66.65 and a 200-day simple moving average of $53.94. The company has a market capitalization of $7.81 billion and a P/E ratio of -6.38. Ralliant Corporation has a 12 month low of $37.27 and a 12 month high of $75.41.
Ralliant (NYSE:RAL – Get Free Report) last announced its quarterly earnings data on Tuesday, May 12th. The company reported $0.57 EPS for the quarter, beating the consensus estimate of $0.49 by $0.08. Ralliant had a negative net margin of 58.55% and a positive return on equity of 12.49%. The business had revenue of $534.60 million during the quarter. The business’s revenue for the quarter was up 11.0% on a year-over-year basis. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. On average, equities research analysts anticipate that Ralliant Corporation will post 2.64 earnings per share for the current year.
Ralliant Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 8th were paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend was Monday, June 8th. Ralliant’s dividend payout ratio is presently -1.83%.
Ralliant Company Profile
Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.
The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.
Further Reading
- Five stocks we like better than Ralliant
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Want to see what other hedge funds are holding RAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ralliant Corporation (NYSE:RAL – Free Report).
Receive News & Ratings for Ralliant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ralliant and related companies with MarketBeat.com's FREE daily email newsletter.
